Generative artificial intelligence (GenAI) has quickly evolved from a novelty to a regular tool in the workplace. It helps ...
The US Food and Drug Administration (FDA) has revised a 2023 draft guidance on master protocols for drug and biological ...
On June 10, 2026, the European Commission published the final Code of Practice (the "Code") on marking and labelling AI-generated content, providing ...
This Collection focuses on cutting-edge mechanisms, smart technologies, and translational medicine in cardiovascular metabolism, emphasizing remodeling and multi-organ signaling. With this ...
This joint-specific response pattern was consistent across all advanced treatment modalities, including abatacept, interleukin-6 receptor inhibitors, Janus kinase inhibitors, rituximab and TNFi.